Studies on hepatocyte growth factor (HGF) in bronchoalveolar lavage (BAL) do not support the concept on its antifibrotic properties in idiopathic pulmonary fibrosis (IPF) Source: International Congress 2015 – Interstitial lung diseases II Year: 2015
Level of cytokines in bronchoalveolar lavage fluid (BALF) in patients with professional lung diseases and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 67s Year: 2001
Induced sputum (IS) in patients with interstitial lung disease (ILD) – comparison with bronchoalveolar lavage (BAL) Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease Year: 2007
Induced sputum versus bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2003; 22: Suppl. 45, 227s Year: 2003
Sputum rather than bronchoalveolar lavage (BAL) cells are associated with small airways function in COPD Source: Eur Respir J 2002; 20: Suppl. 38, 198s Year: 2002
Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry Source: Annual Congress 2005 - Progresses in granolomatous lung disease Year: 2005
Elevated transforming growth factor (TGF)-β1 and thrombospondin (TSP)-1 levels in bronchoalveolar lavage (BAL) fluid of patients with pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 83s Year: 2003
Elevated TGF- b1 concentration in bronchoalveolar lavage fluid from patients with primary lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 585s Year: 2002
Profile of antimicrobial peptides in the bronchoalveolar lavage of patients with interstitial lung diseases Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis Year: 2021
Overexpression of matrix metalloproteinase-7 (MMP-7) in bronchoalveolar lavage fluid (BALF) of IPF and lung cancer patients Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011
Fibrocytes are detected in bronchoalveolar lavage (BAL) fluid in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011
Elevated NT-3 levels in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 586s Year: 2007
Correlation between cellularity of bronchoalveolar lavage (BAL) and parameters of lung function (LF) in patients with sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 180s Year: 2003
Net inflammatory activity of bronchoalveolar lavage fluid (BALF) from patients following lung transplantation Source: Eur Respir J 2002; 20: Suppl. 38, 348s Year: 2002
Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011
Exosomes are differentially present in bronchoalveolar lavage (BAL) of smokers and patients with COPD and IPF Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019
TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC) Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013
Longitudinal evaluation of airway inflammation in stable CF patients by bronchoalveolar lavage (BAL) and influence of rhDNAse Source: Eur Respir J 2002; 20: Suppl. 38, 528s Year: 2002
Studies on interferon-gamma (IFN-γ) expression in lower airways of patients with idiopathic pulmonary fibrosis (IPF), sarcoidosis and pneumoconioses. Lower IFN-γ levels in bronchoalveolar lavage (BAL) supernatants of IPF subgroup with decrease Source: Eur Respir J 2007; 30: Suppl. 51, 121s Year: 2007
The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls Source: International Congress 2014 – ILDs 4 Year: 2014